Caricamento...
Targeting EML4-ALK gene fusion variant 3 in thyroid cancer
Finding targetable gene fusions can expand the limited treatment options in radioactive iodine-refractory (RAI-r) thyroid cancer. To that end, we established a novel cell line ‘JVE404’ derived from an advanced RAI-r papillary thyroid cancer (PTC) patient, harboring an EML4-ALK gene fusion variant 3...
Salvato in:
| Pubblicato in: | Endocr Relat Cancer |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Bioscientifica Ltd
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8183637/ https://ncbi.nlm.nih.gov/pubmed/33878728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-20-0436 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|